Laying a new path for orphan drugs
To go or not to go: the question the UK must answer
EU pharma associations seek orphan drug reform
EFPIA says dedicated facilities not needed if EMA cross-contamination guidance works
Pharma associations take action over national European off-label authorisation laws
EU celebrates 50 years of pharmaceutical legislation
European industry associations seek international co-ordination on cocrystal regulation
Innovative Medicines Initiative moves up a gear
EFPIA calls for more flexibility in EU GMP advice on qualification and validation
Alzheimer’s drug development: Time for a regulatory rethink?
World must keep up the fight against Ebola
Ebola update: progress made but effort must continue
EU/Canada deal: is it fair trade?
EFPIA recommends wider adverse reaction reporting in EU assessments
European Ombudsman calls for transparency in existing clinical trials